Results 121 to 130 of about 14,956 (188)

Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants. [PDF]

Int J Urol
Yasuda Y, Yoshida S, Yonese I, Sano Y, Matsumoto S, Urasaki T, Tamiya T, Tanaka H, Ito M, Miura Y, Numao N, Matsuoka Y, Koga F, Yonese J, Fujii Y.   +14 more
europepmc   +1 more source

Pharmaco-economic profile, effectiveness, and safety of a dolutegravir based first line ART regimen among people living with HIV in South Gujarat. [PDF]

Indian J Med Res
Sojitra B, Patel C, Bhatt KN, Pandya S, Shah P, Shah A, Patel J, Adwani C, Panchal V.   +8 more
europepmc   +1 more source

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. [PDF]

In Vivo
Takada S, Umehara K, Watanabe K.
europepmc   +1 more source

Pyrimidine-based NNRTIs in HIV therapy: advances in synthesis, potency and structure-activity relationships. [PDF]

RSC Adv
Ali H, Hashmi MA, Ajmal N, Goraija MS, Rasool N, Siddiqua UH, Malik A.   +6 more
europepmc   +1 more source

Nicastrin Regulates Cutaneous Squamous Cell Carcinoma Progression Through the MAPK/ERK Signalling. [PDF]

Exp Dermatol
Xue S, Shen Y, Zhang C, Ye Q, Zhang Y, Xu H, He Y.   +6 more
europepmc   +1 more source

Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity. [PDF]

J Dual Diagn
Lynch ST, Mariani JJ, Levin FR.
europepmc   +1 more source

Real-World Outcomes of Olaparib in Japanese Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer: Exploratory Analysis of BRCA2 Loss and Microsatellite Instability Status. [PDF]

Int J Urol
Nukaya T, Naiki T, Watanabe H, Nakane K, Inamoto T, Yasui T, Koie T, Takahara K.   +7 more
europepmc   +1 more source

Efficacy of osimertinib combined with anti-VEGF therapy ramucirumab in managing leptomeningeal metastasis in EGFR-mutant NSCLC: a case report and literature review. [PDF]

J Cardiothorac Surg
Tsai YH, Weng YS, Huang TW.
europepmc   +1 more source

Pyrazolylpyrimidinamines Decorated via Petasis Reaction as Small-Molecule Activators of the RNA-Degrading Ribonuclease IRE1α. [PDF]

ACS Bio Med Chem Au
Avathan Veettil AK, Liu Y, Wagner L, Hastürk O, Huynh NST, Mancino G, Beerbaum M, Wu P.   +7 more
europepmc   +1 more source

Autophagy impairs the sensitivity of Ewing sarcoma cells to PARP inhibitors. [PDF]

Cancer Chemother Pharmacol
Clausen J, Kocher D, Schadwinkel HM, Becker S, Milde T, Beck JF, Sonnemann J.   +6 more
europepmc   +1 more source